Oppenheimer & Co’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-84,525
Closed -$589K 1517
2024
Q2
$589K Buy
+84,525
New +$640K 0.01% 953
2021
Q4
Sell
-7,428
Closed -$207K 1493
2021
Q3
$207K Sell
7,428
-499
-6% -$14.2K ﹤0.01% 1387
2021
Q2
$232K Buy
7,927
+1,100
+16% +$33.3K ﹤0.01% 1370
2021
Q1
$217K Sell
6,827
-3,000
-31% -$88K ﹤0.01% 1317
2020
Q4
$205K Sell
9,827
-200
-2% -$3.73K ﹤0.01% 1240
2020
Q3
$156K Sell
10,027
-9,400
-48% -$162K ﹤0.01% 1193
2020
Q2
$355K Buy
19,427
+69
+0.4% +$1.22K 0.01% 914
2020
Q1
$300K Buy
19,358
+7,363
+61% +$178K 0.01% 899
2019
Q4
$359K Buy
+11,995
New +$312K 0.01% 961
2018
Q4
Sell
-14,734
Closed -$378K 1251
2018
Q3
$378K Sell
14,734
-1,000
-6% -$22.9K 0.01% 972
2018
Q2
$366K Sell
15,734
-4,216
-21% -$87.2K 0.01% 986
2018
Q1
$318K Sell
19,950
-8,775
-31% -$163K 0.01% 1027
2017
Q4
$597K Sell
28,725
-200
-0.7% -$3.17K 0.02% 799
2017
Q3
$415K Buy
28,925
+1,198
+4% +$18.1K 0.01% 911
2017
Q2
$479K Sell
27,727
-6,680
-19% -$80.1K 0.01% 849
2017
Q1
$379K Buy
34,407
+10,647
+45% +$146K 0.01% 903
2016
Q4
$344K Sell
23,760
-6,235
-21% -$114K 0.01% 944
2016
Q3
$737K Buy
29,995
+10,344
+53% +$268K 0.02% 662
2016
Q2
$396K Buy
19,651
+9,944
+102% +$282K 0.01% 870
2016
Q1
$255K Sell
9,707
-748
-7% -$55.3K 0.01% 1000
2015
Q4
$1.06M Buy
10,455
+3,541
+51% +$398K 0.03% 534
2015
Q3
$1.23M Sell
6,914
-23,031
-77% -$5.37M 0.04% 506
2015
Q2
$6.65M Buy
29,945
+3,444
+13% +$764K 0.19% 125
2015
Q1
$5.26M Buy
26,501
+23,141
+689% +$4.11M 0.14% 168
2014
Q4
$481K Sell
3,360
-50
-1% -$6.72K 0.01% 835
2014
Q3
$447K Sell
3,410
-84
-2% -$10K 0.01% 891
2014
Q2
$441K Sell
3,494
-4,474
-56% -$571K 0.01% 899
2014
Q1
$1.05M Buy
7,968
+3,776
+90% +$516K 0.03% 590
2013
Q4
$492K Buy
4,192
+1,431
+52% +$157K 0.02% 814
2013
Q3
$288K Buy
+2,761
New +$269K 0.01% 988

Other funds holding BHC

Oppenheimer & Co's BHC Position: Q3 2024 in Review

Oppenheimer & Co sold out of Bausch Health (BHC) in Q3 2024, closing a stake of 84,525 shares — an estimated $589K sold.

Oppenheimer & Co first reported a position in BHC in Q3 2013 and held it in 30 quarters. The position peaked at $6.65M in Q2 2015. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • Oppenheimer & Co reported no remaining Bausch Health position as of Q3 2024 after selling out during the quarter.
  • Oppenheimer & Co sold 84,525 Bausch Health shares in Q3 2024, an estimated $589K.
  • Oppenheimer & Co first reported a position in Bausch Health in Q3 2013 and held it in 30 quarters.
  • Oppenheimer & Co's Bausch Health position peaked at $6.65M in Q2 2015.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Oppenheimer & Co's 13F filing for Q3 2024, filed 5 Nov 2024.